For Eye Care Professionals
Bausch + Lomb Announces Platinum Sponsorship of the International Keratoconus Academy
Bausch + Lomb Receives Walmart Supplier of the Year Award
Bausch + Lomb Named Exclusive U.S. Distributor of HOYA Surgical Optics’ Intraocular Lens and Injector Portfolio
Bausch + Lomb and IBM Collaborate on Innovative App for iPhone and iPad for Cataract Surgeons on IBM Cloud
Bausch + Lomb Reports Preliminary 2015 Results of the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Study
Bausch + Lomb Receives FDA Approval of TRULIGN® Toric IOL Calculator Enhancements, Announces Capsular Tension Ring Addition, and Showcases Latest Innovations in its Product Portfolio During the ASCRS Annual Meeting in New Orleans
Bausch + Lomb Highlights Scientific and Clinical Research during the Association for Research in Vision and Ophthalmology Annual Meeting in Seattle, WA
New Bausch + Lomb Campaign Asks Consumers “Are Your Contacts Still Comfortable?”
Bausch + Lomb Names Greg DiPasquale as Vice President of Sales for US Vision Care Business
Bausch + Lomb Educates 400+ Eye Care Professionals on the Latest in Contact Lens Technology During B+Lieve™ Innovation Summit
Bausch + Lomb ULTRA® for Presbyopia Contact Lenses Introduced During SECO International in Atlanta, GA
Americans Share What Inspires Them to Fight to Help Preserve Their Vision
Bausch + Lomb Donates $50,000 to Optometry Giving Sight
Bausch + Lomb Expands Specialty Lens Business with the Addition of Alden Optical Laboratories, Inc.
Bausch + Lomb Announces 2016 Elite Vendor Relationship with Vision Source
Bausch + Lomb Presents Products, Surgical Platforms and Newly Expanded Retina Offerings During the Annual Meeting of the American Academy of Ophthalmology in Las Vegas
Bausch + Lomb Announces 2016 Launch of Bausch + Lomb ULTRA® Contact Lenses for Presbyopia
Five-Year Results of the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Study Published in JAMA Ophthalmology
Bausch + Lomb Acquires Doctor’s Allergy Formula Diagnostic System
Bausch + Lomb and Nicox Announce FDA Acceptance of New Drug Application for Novel Glaucoma Candidate Latanoprostene Bunod